IL-28A/IFN-lambda 2 Antibody (248526) [Unconjugated]
| Name | IL-28A/IFN-lambda 2 Antibody (248526) [Unconjugated] |
|---|---|
| Supplier | Novus Biologicals |
| Catalog | MAB1587 |
| Prices | $99.00, $269.00 |
| Sizes | 25 µg, 100 µg |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | 248526 |
| Applications | B/N |
| Species Reactivities | Human |
| Antigen | Mouse myeloma cell line NS0-derived recombinant human IL‑28A/IFN‑ lambda 2 Val26-Val200 Accession # Q8IZJ0 |
| Description | Mouse Monoclonal |
| Gene | IFNL2 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Recombinant HumanIL‑28A/IFN‑ lambda 2 (Catalog #1587‑IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Human IL‑28A/IFN‑ lambda 2 (0.1 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti‑Human IL‑28A/IFN‑ lambda 2 Monoclonal Antibody (Catalog # MAB1587). The ND50 is typically 0.25‑1.0 µg/mL.